The sale of bluebird bio and Pfizer’s decision to drop a gene therapy for hemophilia ... breakthroughs and struggles in the bigger arc of biotechnology. The CGT story looks a lot like monoclonal ...

The ExPERT and IRO platforms were integrated to improve the yield of gene-edited T cells and shorten manufacturing timelines.

Get Instant Summarized Text (Gist) Generative AI has been used to design synthetic DNA regulatory sequences that precisely control gene expression in healthy mammalian cells. These AI-generated ...

MaxCyte and Ori Biotech successfully integrate their ExPERT™ and IRO® platforms to improve the yield of gene-edited T cells and shorten manufacturing timelines. ROCKVILLE, Md.

According to clinical guidelines, high-risk myeloma patients should receive intensified treatment regimens. However, heterogeneity in clinical markers and staging systems lead to various interpretatio ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has initiated the human trial of ARO-ALK7, a novel RNA interference (RNAi) ...

Telomir Pharma’s Telomir-1 shows dose-dependent restoration of neurological, liver & kidney functions in preclinical for Wilson’s disease: Miami, Florida Saturday, June 14, 20 ...

MaxCyte, a Rockville, Maryland-based cell engineering technology company, said its Flow Electroporation technology, which is already used in over 19 clinical and commercial programs, will be paired ...